指南与共识自身炎症与 IgG4 相关病

2019年ACR/EULAR IgG4相关疾病分类标准

The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
指南 / 共识 · Ann Rheum Dis · 2019-12-03

该标准由ACR/EULAR组织86名多学科医师制定,采用共识、文献、1879例受试者(1086例病例、793例模拟者)的推导与验证队列及多准则决策分析。分类分三步:器官受累、32项排除标准、8个加权纳入域;验证队列中阈值20分时特异度分别为99.2%和97.8%,敏感度分别为85.5%和82.0%。

要点

  • 分类需先确认11个可能器官中至少1个的IgG4-RD相容性受累。
  • 应用32项临床、血清学、放射学及病理学排除标准,任一存在即不能分类。
  • 8个加权纳入域总分≥20分时,验证队列特异度99.2%/97.8%,敏感度85.5%/82.0%。

核心结论

  • ACR/EULAR IgG4-RD分类标准已在大规模队列中制定并验证,测试性能优异,应有助于未来临床、流行病学和基础研究。

研究设计与样本

  • ACR/EULAR组建86名医师的国际多学科组,使用共识练习、现有文献、1879例受试者(1086例病例、793例模拟者)的推导与验证队列及多准则决策分析制定并验证分类标准。

主要发现

  • 建立三步分类流程:首先证明至少1个11种可能器官的IgG4-RD相容性受累。
  • 第二步应用共32项临床、血清学、放射学及病理学排除标准,任一存在即排除分类。
  • 第三步应用8个加权纳入标准域,涵盖临床、血清学、放射学及病理学解释。
  • 第一验证队列阈值20分时特异度99.2%(95%CI 97.2%至99.8%),敏感度85.5%(95%CI 81.9%至88.5%)。
  • 第二验证队列特异度97.8%(95%CI 93.7%至99.2%),敏感度82.0%(95%CI 77.0%至86.1%)。

关键数值与推荐

  • 分类阈值20分在验证队列中特异度99.2%(95%CI 97.2%至99.8%)、敏感度85.5%(95%CI 81.9%至88.5%)。
  • 第二验证队列阈值20分时特异度97.8%(95%CI 93.7%至99.2%)、敏感度82.0%(95%CI 77.0%至86.1%)。
  • 标准在广泛阈值范围内均显示稳健的测试特征。

临床怎么用

  • 临床分类IgG4-RD时按三步流程:确认器官受累、排除32项标准、计算8个加权域总分并以20分为阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IgG4-related disease (IgG4-RD) can cause fibroinflammatory lesions in nearly any organ. Correlation among clinical, serological, radiological and pathological data is required for diagnosis. This work was undertaken to develop and validate an international set of classification criteria for IgG4-RD. An international multispecialty group of 86 physicians was assembled by the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). Investigators used consensus exercises; existing literature; derivation and validation cohorts of 1879 subjects (1086 cases, 793 mimickers); and multicriterion decision analysis to identify, weight and test potential classification criteria. Two independent validation cohorts were included. A three-step classification process was developed. First, it must be demonstrated that a potential IgG4-RD case has involvement of at least one of 11 possible organs in a manner consistent with IgG4-RD. Second, exclusion criteria consisting of a total of 32 clinical, serological, radiological and pathological items must be applied; the presence of any of these criteria eliminates the patient from IgG4-RD classification. Third, eight weighted inclusion criteria domains, addressing clinical findings, serological results, radiological assessments and pathological interpretations, are applied. In the first validation cohort, a threshold of 20 points had a specificity of 99.2% (95% CI 97.2% to 99.8%) and a sensitivity of 85.5% (95% CI 81.9% to 88.5%). In the second, the specificity was 97.8% (95% CI 93.7% to 99.2%) and the sensitivity was 82.0% (95% CI 77.0% to 86.1%). The criteria were shown to have robust test characteristics over a wide range of thresholds. ACR/EULAR classification criteria for IgG4-RD have been developed and validated in a large cohort of patients. These criteria demonstrate excellent test performance and should contribute substantially to future clinical, epidemiological and basic science investigations.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2019. PMID: 31796497. doi:10.1136/annrheumdis-2019-216561

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。